What is Acumen Pharmaceuticals Inc's share price today?
Acumen Pharmaceuticals Inc (ABOS) share price today is $2.84 as of September 16, 2026 at 9:46 PM IST. The stock touched a day high of $2.95 and a day low of $2.84.What exchange does Acumen Pharmaceuticals Inc stock trade on, and under what ticker symbol?
Acumen Pharmaceuticals Inc stock trades on NASDAQ under the ticker symbol ABOS.What is Acumen Pharmaceuticals Inc's market capitalization?
Acumen Pharmaceuticals Inc's market capitalization is $201.76M as of September 16, 2026 at 9:46 PM IST.What is Acumen Pharmaceuticals Inc's price-to-earnings (P/E) ratio?
Acumen Pharmaceuticals Inc's price-to-earnings (P/E) ratio is N/A as of September 16, 2026.What is Acumen Pharmaceuticals Inc's price-to-book (P/B) ratio?
Acumen Pharmaceuticals Inc's price-to-book (P/B) ratio is 3.69 as of September 16, 2026.Can Indian investors buy Acumen Pharmaceuticals Inc shares?
Yes, You can buy Acumen Pharmaceuticals Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Acumen Pharmaceuticals Inc shares from India?
Indian investors can buy Acumen Pharmaceuticals Inc shares in three steps: 1. Search Acumen Pharmaceuticals Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Acumen Pharmaceuticals Inc shares for Indian investors?
Since Acumen Pharmaceuticals Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Acumen Pharmaceuticals Inc shares via Tickertape?
Indian investors can start investing in Acumen Pharmaceuticals Inc (ABOS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.5149 shares at the current price of $2.84.
$
₹
$2.841.55% (-0.04)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
3.69
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-1.64
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 5 analysts' reports
Buy5 analysts
Hold0 analyst
Sell0 analyst
Analysts expect a +165.23% price upside over the next year
Current Price$2.84
Target Price$7.4
Company Profile
Peers
Peers
ABBV
P/E Ratio
73.73
73.73
1Y Return
21.16%
21.16%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
23.68
23.68
1Y Return
37.87%
37.87%
Buy Reco %
46.87
46.87
P/E Ratio
—
—
1Y Return
29.99%
29.99%
Buy Reco %
63.33
63.33
P/E Ratio
30.27
30.27
1Y Return
30.87%
30.87%
Buy Reco %
52.94
52.94
P/E Ratio
19.64
19.64
1Y Return
35.36%
35.36%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals Inc | - | 3.69 | - |
| AbbVie Inc | 73.73 | 50.45 | 0.52 |
| Amgen Inc | 23.68 | 17.45 | 2.27 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | - | - | -0.04 | -0.04 | - |
| Net Income | -14.87 | -20.53 | -29.76 | -37.15 | -28.79 | -40.95 | -26.45 | -25.13 | -20.73 | -32.71 |
| Net Profit Margin | - | - | - | -20873.03% | - | - | - | - | - | - |